Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can "own NOW and what’s NEXT"

August 30, 2024 7:30 AM

TORONTO, ON / ACCESSWIRE / August 30, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that highly-anticipated launch of unbuzzd™, a groundbreaking product designed to help individuals recover from the adverse effects of alcohol consumption and prepare for what's next....

Read more

Palliative Care Market Foresees a Sluggish Road in the Foreseeable Future, with an Expected CAGR of 2.8% until 2034, Predict FMI’s Analysts

August 30, 2024 7:00 AM

The palliative care market foresees its current market valuation at USD 13.45 billion in 2024 and is predominantly considered to surge at a valuation of USD 17.73 billion by 2034, projected at a CAGR of 2.8%.Research for the palliative care market demonstrates integrating palliative care alongside curative treatments that improvised symptom management, embellished patient and family satisfaction, and reduced hospitalizations.Healthcare systems...

Read more

iZafe Group Q2 Interim Report, April-June 20234

August 30, 2024 2:50 AM

STOCKHOLM, SE / ACCESSWIRE / August 30, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ.) presents today, August 30, its report for the second quarter.Financial Performance in SummaryNet sales for the quarter amounted to SEK 168 thousand (SEK 403 thousand). The decrease in sales during the quarter is primarily attributable to an adjustment of previously invoiced amounts from Q1. Approximately 5% of the units produced did not meet quality...

Read more

Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update

August 30, 2024 1:25 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today reported its financial results for the half-year ended June 30, 2024, and provided a corporate update. Relief provided updates on its key development programs and strategic initiatives, including RLF-TD011, a hypochlorous...

Read more

Glioblastoma Foundation Genomic Testing & Research Laboratory Ribbon-Cutting Ceremony on Sept. 3rd

August 29, 2024 8:00 PM

Opening of testing lab ushers in a new era of targeted treatments to change glioblastoma diagnosis from terminal to treatableDURHAM, NC / ACCESSWIRE / August 29, 2024 / The Glioblastoma Foundation is hosting a welcome ceremony to inaugurate its innovative Genomic Testing & Research Laboratory, a first-of-its-kind lab in the U.S. The cutting-edge laboratory is set to revolutionize the fight against glioblastoma by offering patients access to...

Read more

Dallas Medical Waste Disposal Company Confronts Alarming Rate of Needlestick Injuries With Detailed Guide

August 29, 2024 1:11 PM

The CDC reports an estimated 385,000 needlestick and sharps-related injuries among U.S. healthcare workers every year.DALLAS, TX / ACCESSWIRE / August 29, 2024 / In light of the increasing frequency of needlestick injuries, BioMedical Waste Solutions, a prominent provider of medical waste disposal services with locations in Dallas, TX, is actively working to inform the public about the dangers associated with improper disposal of medical waste,...

Read more

How to Prioritize Your Dental Health in Jonesboro

August 29, 2024 12:30 PM

Good dental health doesn't just keep your smile looking good. It also helps prevent painful and inconvenient conditions like gum disease, tooth decay, cavities, and even tooth loss.What you do at home is a great start, but neglecting dental visits can cause you to miss spots and fail to catch signs of potential issues early on.This article explains what to do at home and at your dentist in Jonesboro, AR, to prioritize your dental health.What to...

Read more

MyMenopauseRx Partners With MyUTI to Enhance Access to Virtual UTI Care for Midlife Women

August 29, 2024 12:00 PM

Revolutionizing Midlife Healthcare: New Collaboration Expands Access to Advanced Virtual UTI and Menopause CareWHEATON, IL / ACCESSWIRE / August 29, 2024 / MyMenopauseRx, a virtual doctor's office dedicated to menopause care covered by health insurance, is thrilled to announce its partnership with MyUTI. This collaboration aims to improve access to virtual UTI care for midlife women born with ovaries, further closing the menopause health equity...

Read more

Quest Diagnostics Empowers Employees With Enhanced Education Assistance and Career Growth Programs, Achieving Record Engagement in 2023

August 29, 2024 11:10 AM

NORTHAMPTON, MA / ACCESSWIRE / August 29, 2024 / Quest Diagnostics:Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportOur employees don't just hold jobs-they build careers. In 2023, we continued to focus on the hire-to-retire journey for our workforce. Learning and development programs, education assistance, and opportunities to improve our organizational culture make Quest a place to grow and advance.MY QUEST FOR...

Read more

The GORE-TEX Brand: The Iconic Ingredient Brand’s Journey to Responsible Performance (Part 1)

August 29, 2024 10:30 AM

NORTHAMPTON, MA / ACCESSWIRE / August 29, 2024 / Gore:In the first part of the HeroInside podcast Gore Fabrics Global Business Leader Achim Loeffler and host Tomas Vucurevic talk about the GORE-TEX brand, its beginnings and how it evolved to get the iconic brand that it is today. Achim touches on the foundation of W. L. Gore & Associates by Bill and Vieve Gore in 1958 and explains how their son Bob Gore discovered ePTFE (expanded...

Read more

REMORY, a Supplement Currently Receiving Widespread Attention, Announces Packaging Redesign for the U.S. Market

August 29, 2024 10:00 AM

REMORY: Elevate Cognitive Health with Unique Sea Squirt-Derived Plasmalogens. Now in the U.S., this Japanese-Innovated Supplement Combines EPA, DHA, and Omega-3s for Enhanced Memory and Brain Function in Aging Adults. Recognized by Japan as a 'Food with Functional Claims,' REMORY is FDA-Notified, Setting a New Standard in Natural Cognitive Support.LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / Since its launch in the United States, the...

Read more

SpendMend Welcomes Jon Weibel as New Vice President of Strategic Accounts

August 29, 2024 9:00 AM

GRAND RAPIDS, MI / ACCESSWIRE / August 29, 2024 / SpendMend, a leading provider of cost-saving solutions for the healthcare industry, today announced the addition of Jon Weibel as Vice President of Strategic Accounts. Weibel brings with him a wealth of experience in strategic consulting and custom solutions delivery, further strengthening SpendMend's position as a premier provider of cost-saving solutions in the healthcare industry.Jon Weibel,...

Read more

KindlyMD(TM) Appoints Jeremy Joyal, MD as Medical Director

August 29, 2024 9:00 AM

Dr. Joyal, a licensed physician with board certifications in Anesthesiology, Pain Medicine, and Addiction Medicine, will oversee the Company's clinical practices and develop program protocols for pain managementSALT LAKE CITY, UT / ACCESSWIRE / August 29, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management...

Read more

Moderna Launches National Awareness Campaign to Help Drive COVID-19 Vaccination

August 29, 2024 8:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced the launch of its new awareness campaign, "Do It For You & Them." The initiative is part of Moderna's broader efforts to drive vaccination rates in the United States as COVID-19 infection rates continue to be elevated across the country."COVID-19 remains a significant health risk and is a leading cause of respiratory illness-related hospitalization, regardless of age or health condition," said...

Read more

CBD Life Sciences, Inc. (CBDL) Announces MOU With New York Dispensary, Poised for Significant Revenue Growth and Shareholder Value

August 29, 2024 8:00 AM

The targeted acquisition is estimated to have a business value of approximately $10 million and projected 2024 gross revenues of up to $4.5 millionSCOTTSDALE, AZ / ACCESSWIRE / August 29, 2024 / CBD Life Sciences, Inc. (OTC PINK:CBDL), a leading publicly traded company in the CBD industry, is pleased to announce the signing of a Memorandum of Understanding (MOU) with a prominent entity in the cannabis sector. This strategic agreement signifies a...

Read more

Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product

August 29, 2024 6:30 AM

Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering therapeutic and diagnostic products for equine and companion animals, is pleased to announce that its Assisi Loop® product line is continuing its designation as a Fear Free Preferred Product. Fear Free, a globally recognized initiative dedicated to reducing fear, anxiety, and stress in pets, reaffirmed its validation of Assisi's targeted pulsed...

Read more

Bioz and PCR Biosystems Team Up to Revolutionize PCR Research With Cutting-Edge AI Insights

August 29, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / August 29, 2024 / Bioz, Inc., a leader in AI-driven research solutions, is excited to announce a dynamic new collaboration with PCR Biosystems, a rising star in the world of PCR technology. This partnership is set to redefine the way researchers discover and evaluate PCR products, bringing unprecedented AI capabilities to the forefront of scientific research.Bioz Prime BadgeBioz Prime Badge on PCR Biosystems'...

Read more

Berlin Cures Welcomes Renowned Immunologist Professor Danny Altmann to its Advisory Board

August 29, 2024 2:10 AM

Berlin Cures, a biotechnology company in Phase II clinical trial for a treatment against Long COVID and other autoimmune diseases, is pleased to announce the appointment of Professor Danny Altmann to its Advisory Board. Altmann, a distinguished immunologist from the Imperial College London, will bring invaluable expertise to the company's drug research and development efforts focused on autoimmune diseases, including Long COVID. The role of the...

Read more

Patients for Patient Safety US Announces Film Premiere of 'The Pitch: Patient Safety’s Next Generation' at World Patient Safety Day 2024 DC Summit

August 28, 2024 7:40 PM

WASHINGTON, D.C. / ACCESSWIRE / August 28, 2024 / From Sept. 15-17, patient safety advocates are convening in Washington, D.C., for a series of events commemorating World Patient Safety Day (WPSD). As part of the WPSD 2024 DC Summit, Patients for Patient Safety US is teaming up with AcademyHealth to host a premiere of The Pitch: Patient Safety's Next Generation, a new documentary from Mike Eisenberg, director of 2018 film To Err Is Human: A...

Read more

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

August 28, 2024 4:10 PM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, will participate in a fireside chat at the 2024 Wells Fargo Healthcare Conference on Thursday, September 5, 2024 at 10:15 am EST. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation.About...

Read more